Olympia Pharmaceuticals Expands into Alabama with New Licensing, Bringing GLP-1s and More to Healthcare Providers

Nation’s leading compound pharmacy is now available in 48 states

ORLANDO, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — Olympia Pharmaceuticals, a state-of-the-art, FDA-registered 503B pharmaceutical outsourcing facility, is proud to announce its expansion into Alabama, following successful licensing in the state. This marks a significant milestone in the company’s continued growth and ability to serve healthcare providers nationwide.

Olympia is now able to offer a range of high-quality compounded medications to healthcare professionals across Alabama. With an increasing demand for weight loss solutions and IV nutritional therapies, Olympia is uniquely positioned to meet these needs with products like GLP-1s and IV Nutrition, among others.

As the nation’s leading 503B facility, Olympia has earned a strong reputation for providing consistent, effective, and high-quality compounded medications, serving 48 states. The addition of Alabama to Olympia’s roster further strengthens the company’s nationwide footprint and its commitment to supporting healthcare providers and pharmacies with critical treatment options.

“We are excited to announce our expansion into Alabama and the opportunity to support physicians throughout the region,” said Mark Mikhael, CEO of Olympia. “With the growing demand for health and wellness solutions, we are confident in our ability to positively impact the drug supply chain in Alabama.”

With an extensive portfolio of compounded solutions, including GLP-1s, weight loss medications, and IV nutrition formulations, Olympia Pharmaceuticals is positioned to be a trusted partner for Alabama healthcare providers. The company’s dedication to quality service ensures that physicians and pharmacies have the medications they need, when they need them.

If you are a healthcare provider in Alabama, visit www.olympiapharmacy.com to learn more about Olympia Pharmaceuticals’ product offerings and how it can support your practice with compounded medications tailored to your patients’ needs.

About Olympia Pharmaceuticals
Olympia Pharmaceuticals is a state-of-the-art, FDA 503B pharmaceutical outsourcing facility supporting both patient-specific and office-use needs across the U.S. The team is made up of pharmacy technicians, pharmacists, microbiologists and engineers, creating an educated and experienced staff knowledgeable in all facets of pharmacy. As an FDA-registered, full-service pharmacy, Olympia offers traditional, over the counter and compounded medications with an extensive inventory of compounded chemicals and traditional medications and is the only outsourcing facility located in Central Florida.

Media Contact
Hannah Williams
Uproar by Moburst for Olympia Pharmaceuticals
hannah.williams@moburst.com

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

29 minutes ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

3 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

3 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

3 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

3 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

3 hours ago